…erebrovascular accidents (n=7), post-COVID-19 neuropathy (n=5), amyotrophic lateral sclerosis (n=4), chronic inflammatory demyelinating polyneuropathy (n=4),…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 125 of 2459…ham from inception to May 2025. The search terms applied were: ‘Wolfram syndrome’, ‘insulin pump’ and ‘continuous glucose monitoring’, with the …
…chaemic stroke and retain importance for selected patients with ST-elevation myocardial infarction and pulmonary embolism. Pharmacological and practical advantage…
…ociated with LHI (coefficient=−0.049, 95% CI −0.084 to –0.015). Diabetes showed stronger positive effects on LPI (coefficient=0.093, 95%…
…organisations. Adults (≥18 years) prescribed a fluoroquinolone (ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin, delafloxacin, gemifloxa…
…HIV diagnosis can be especially challenging in persons using long-a…
…Objectives Both telitacicept and belimumab are approved for treating active systemic lupus erythematosus (…
…5% female). Resolution of at least one T2-lesion differentiated MOGAD from MS (sensitivity, (95% CI 77% to 100%), specificity, (95% C…
…e completed successfully. Forty-one patients with rGBM received bevacizumab-SIACI, 7 with ndGBM bevacizumab-SIACI, and 22 with ndGBM cetuximab-SI…
… tests for rubella (N=211 917) or B19V (N=644 473) performed at Labcorp from 2014 to 2023. Among these participants, participants with …
…sidence (interaction aOR 0.84, 95% CI 0.70 to 0.98).Conclusions Obesity disproportionately affected women, although association with so…
…development (adjusted OR=0.65, 95% CI 0.39 to 1.09).Conclusions Pneumoconiosis is associated with an increased risk of cataract. Routine ophth…